Survey on Crude Drug Usage in Japan (3)

  • Yamamoto Yutaka
    Crude Drugs Committee, Japan Kampo Medicines Manufacturers Association (JKMA)
  • Isozaki Takafumi
    Crude Drugs Committee, Japan Kampo Medicines Manufacturers Association (JKMA)
  • Kitamaki Yuki
    Crude Drugs Committee, Japan Kampo Medicines Manufacturers Association (JKMA)
  • Kurata Kiyoshi
    Crude Drugs Committee, Japan Kampo Medicines Manufacturers Association (JKMA)
  • Taira Masayo
    Crude Drugs Committee, Japan Kampo Medicines Manufacturers Association (JKMA)
  • Takeda Osami
    Crude Drugs Committee, Japan Kampo Medicines Manufacturers Association (JKMA)
  • Yamaguchi Yoshihiro
    Crude Drugs Committee, Japan Kampo Medicines Manufacturers Association (JKMA)
  • Sasaki Hiroshi
    Crude Drugs Committee, Japan Kampo Medicines Manufacturers Association (JKMA)

Bibliographic Information

Other Title
  • 日本における原料生薬の使用量に関する調査報告(3)
  • ニホン ニ オケル ゲンリョウ ショウヤク ノ シヨウリョウ ニ カンスル チョウサ ホウコク(3)

Search this article

Description

<p>The survey on the variety, amount and producing countries of crude drugs for medicinal use was conducted among member companies belonging to Japan Kampo Medicines Manufacturers Association in fiscal 2019 and 2020. The results showed that total amount of use and number of items of crude drugs were 27,240 tons of 273 items in 2019, and 27,997 tons of 276 items in 2020, respectively. Comparing production ratios among countries, Japan, China and the other countries produced 9.9%, 83.8% and 6.3% of the total amount used in 2019, respectively. Similarly, each ratio turned to 10.3%, 82.7% and 7.0% in 2020. </p>

Journal

  • Shoyakugaku Zasshi

    Shoyakugaku Zasshi 77 (1), 24-41, 2023-02-20

    The Japanese Society of Pharmacognosy

Details 詳細情報について

Report a problem

Back to top